Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 6,389,343 |
|
|||||
| News | - | ||||||
| Day High | 0.0243 | Low High |
|||||
| Day Low | 0.0209 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Enzolytics Inc (PK) | ENZC | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.00181 | -7.72% | 0.02165 | 15:00:58 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.023 | 0.0209 | 0.0243 | 0.02165 | 0.02346 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 250 | 6,389,343 | US$ 0.02245 | US$ 143,439 | - | 0.016 - 0.132 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 14:59:35 | 200 | US$ 0.02165 | USD |
Enzolytics Inc (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 61.68M | 3.01B | -1.98B | 0 | -2.94M | -0.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Enzolytics (PK) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/20/2023 | 07:14 | InvestorsHub NewsWire | Small Cap Recipient of Military Drone Technology |
| 5/03/2023 | 11:24 | InvestorsHub NewsWire | MWRK Positions For High Growth In $3.5 Trillion Metaverse.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ENZC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0232 | 0.027 | 0.0209 | 0.0245601 | 3,522,961 | -0.00155 | -6.68% |
| 1 Month | 0.0255 | 0.027 | 0.016 | 0.0225742 | 7,334,224 | -0.00385 | -15.1% |
| 3 Months | 0.042 | 0.06025 | 0.016 | 0.0327982 | 6,888,892 | -0.02035 | -48.45% |
| 6 Months | 0.0409 | 0.06025 | 0.016 | 0.0390038 | 6,754,683 | -0.01925 | -47.07% |
| 1 Year | 0.0406 | 0.132 | 0.016 | 0.0527671 | 7,886,271 | -0.01895 | -46.67% |
| 3 Years | 0.0951 | 0.958 | 0.016 | 0.1655955 | 15,646,161 | -0.07345 | -77.23% |
| 5 Years | 0.0025 | 0.958 | 0.0001 | 0.0702629 | 27,049,709 | 0.01915 | 766.0% |
Enzolytics (PK) Description
| Business Description Enzolytics, Inc. (the "Company" or "ENZC") is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The Company is committed to creating drugs for the better health of mankind. ENZC's flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from major neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective. |
